Roger G. Melton

1.7k total citations
31 papers, 1.3k citations indexed

About

Roger G. Melton is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Roger G. Melton has authored 31 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Oncology. Recurrent topics in Roger G. Melton's work include Monoclonal and Polyclonal Antibodies Research (16 papers), Cancer Research and Treatments (10 papers) and Peptidase Inhibition and Analysis (7 papers). Roger G. Melton is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (16 papers), Cancer Research and Treatments (10 papers) and Peptidase Inhibition and Analysis (7 papers). Roger G. Melton collaborates with scholars based in United Kingdom, United States and Australia. Roger G. Melton's co-authors include Roger F. Sherwood, Richard J. Knox, Frank Friedlos, Philip J. Burke, Peter Hughes, Kenneth D. Bagshawe, Brian Coles, Surinder K. Sharma, Alec D. Tucker and G.T. Rogers and has published in prestigious journals such as Journal of Molecular Biology, Cancer and Cancer Research.

In The Last Decade

Roger G. Melton

31 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roger G. Melton United Kingdom	18	882	389	309	276	239	31	1.3k
Melissa Millard United States	14	1.1k 1.3×	73 0.2×	298 1.0×	132 0.5×	172 0.7×	18	1.9k
Brenda Kellogg United States	10	819 0.9×	331 0.9×	345 1.1×	50 0.2×	121 0.5×	13	1.2k
Patrick Burke United States	16	724 0.8×	830 2.1×	880 2.8×	45 0.2×	270 1.1×	57	1.7k
Yohei Saito Japan	21	632 0.7×	85 0.2×	214 0.7×	56 0.2×	228 1.0×	82	1.2k
Francisco Javier Rodrı́guez-Berrocal Spain	22	677 0.8×	70 0.2×	442 1.4×	61 0.2×	109 0.5×	61	1.4k
Kun Chen China	18	1.3k 1.5×	58 0.1×	155 0.5×	97 0.4×	101 0.4×	49	1.7k
Christopher P. Guise New Zealand	23	858 1.0×	41 0.1×	239 0.8×	334 1.2×	165 0.7×	51	1.6k
A. H. Blair Canada	18	468 0.5×	350 0.9×	154 0.5×	45 0.2×	69 0.3×	31	1.1k
Bronwyn G. Siim New Zealand	17	738 0.8×	58 0.1×	276 0.9×	122 0.4×	245 1.0×	23	1.4k
Yumiko Ohta Japan	17	503 0.6×	71 0.2×	173 0.6×	97 0.4×	53 0.2×	46	855

Countries citing papers authored by Roger G. Melton

Since Specialization

Citations

This map shows the geographic impact of Roger G. Melton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger G. Melton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger G. Melton more than expected).

Fields of papers citing papers by Roger G. Melton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger G. Melton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger G. Melton. The network helps show where Roger G. Melton may publish in the future.

Co-authorship network of co-authors of Roger G. Melton

This figure shows the co-authorship network connecting the top 25 collaborators of Roger G. Melton. A scholar is included among the top collaborators of Roger G. Melton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger G. Melton. Roger G. Melton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Auton, T.R., et al.. (2007). In vitro demonstration that pemetrexed is a good substrate for glucarpidase. Cancer Research. 67. 4773–4773. 2 indexed citations

Knox, Richard J., Terence C. Jenkins, Stephen M. Hobbs, et al.. (2000). Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapy.. PubMed. 60(15). 4179–86. 89 indexed citations

Bagshawe, Kenneth D., Philip J. Burke, Richard J. Knox, Roger G. Melton, & Surinder K. Sharma. (1999). Targeting enzymes to cancers - new developments. Expert Opinion on Investigational Drugs. 8(2). 161–172. 6 indexed citations

Bagshawe, Kenneth D., Surinder K. Sharma, Philip J. Burke, Roger G. Melton, & Richard J. Knox. (1999). Developments with targeted enzymes in cancer therapy. Current Opinion in Immunology. 11(5). 579–583. 35 indexed citations

Rowsell, Siân, Richard A. Pauptit, Alec D. Tucker, et al.. (1997). Crystal structure of carboxypeptidase G2, a bacterial enzyme with applications in cancer therapy. Structure. 5(3). 337–347. 152 indexed citations

Melton, Roger G.. (1996). Preparation and purification of antibody-enzyme conjugates for therapeutic applications. Advanced Drug Delivery Reviews. 22(3). 289–301. 14 indexed citations

Knox, R.J., Steve Hobbs, T.C. Jenkins, et al.. (1996). Investigation of alternative prodrugs for use with E. coli nitroreductase in 'suicide gene' approaches to cancer therapy.. PubMed. 3(12). 1143–50. 35 indexed citations

Tucker, Alec D., et al.. (1996). A new crystal form of carboxypeptidase G₂fromPseudomonassp. strain RS-16 which is more amenable to structure determination. Acta Crystallographica Section D Biological Crystallography. 52(4). 890–892. 4 indexed citations

Anlezark, Gill, Roger G. Melton, Roger F. Sherwood, et al.. (1995). Bioactivation of dinitrobenzamide mustards by an E. coli B nitroreductase. Biochemical Pharmacology. 50(5). 609–618. 73 indexed citations

10.

Skelly, Jane V., et al.. (1994). Crystallization and Preliminary Crystallographic Data for an FMN-dependent Nitroreductase from Escherichia coli B. Journal of Molecular Biology. 238(5). 852–853. 8 indexed citations

11.

Bagshawe, Kenneth D., Philip J. Burke, Joan A. Boden, et al.. (1994). Galactosylated antibodies and antibody-enzyme conjugates in antibody-directed enzyme prodrug therapy. Cancer. 73(S3). 1114–1120. 40 indexed citations

12.

Rose, Keith, et al.. (1994). Site-Specific Conjugation of an Enzyme and an Antibody Fragment. Bioconjugate Chemistry. 5(5). 411–417. 17 indexed citations

13.

Melton, Roger G., et al.. (1993). Tumour necrosis factor increases tumour uptake of Co-administered antibody-carboxypeptidase G2 conjugate. European Journal of Cancer. 29(8). 1177–1183. 11 indexed citations

14.

Blakey, D C, B. Valcaccia, Caroline J. Springer, et al.. (1993). Antitumor effects of an antibody-carboxypeptidase g2 conjugate in combination with a benzoic acid mustard prodrug. Cell Biophysics. 22(1-3). 1–8. 16 indexed citations

15.

Melton, Roger G., et al.. (1993). Optimisation of small-scale coupling of A5B7 monoclonal antibody to carboxypeptidase G2. Journal of Immunological Methods. 158(1). 49–56. 34 indexed citations

16.

Knox, Richard J., et al.. (1992). The bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954)—II. Biochemical Pharmacology. 44(12). 2297–2301. 85 indexed citations

17.

Melton, Roger G., et al.. (1992). The bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954)—I. Biochemical Pharmacology. 44(12). 2289–2295. 183 indexed citations

18.

Sharma, Surinder K., Kenneth D. Bagshawe, Roger G. Melton, & Roger F. Sherwood. (1992). Human immune response to monoclonal antibody-enzyme conjugates in ADEPT pilot clinical trial. Cell Biophysics. 21(1-3). 109–120. 54 indexed citations

19.

Springer, Caroline J., Kenneth D. Bagshawe, Surinder K. Sharma, et al.. (1991). Ablation of human choriocarcinoma xenografts in nude mice by antibody-directed enzyme prodrug therapy (ADEPT) with three novel compounds. European Journal of Cancer and Clinical Oncology. 27(11). 1361–1366. 86 indexed citations

20.

Sherwood, Roger F., et al.. (1985). Purification and properties of carboxypeptidase G2 from Pseudomonas sp. strain RS-16. Use of a novel triazine dye affinity method. European Journal of Biochemistry. 148(3). 447–453. 175 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact